@article{4f4efbe02e504c13af37b6d18923131d,
title = "COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience",
author = "Neha Mehta-Shah and Bartlett, \{Nancy L.\} and Brad Kahl and Watkins, \{Marcus P.\} and Amalia Dubois and Gabby Schmelzle and Saiama Waqar and Claire Ballman and Fei Wan and Farnsworth, \{Christopher W.\}",
note = "Funding Information: N.M-S has research funding from Bristol Myers-Squibb, Astrazeneca Pharmaceuticals, Celgene, Secura Bio, Verastem, Roche/Genentech, C4 Therapeutics, Corvus, Innate Pharmaceuticals, Daiichi Sankyo. N. M-S has consulted for Secura Bio, Daiichi sankyo, C4 Therapeutics, Karyopharm Therapeutics, Kyowa Hakka Kirin. N.L.B has research funding from ADC Therapeutics, Affimed, Autolus, Bristol-Myers Squibb, Celgene, Forty Seven, Immune Design, Janssen, Kite Pharma/Gilead, Merck, Millennium, Pharmacyclics, Pfizer, Roche/Genentech, and SeaGen, and been on advisory boards for Acerta, ADC Therapeutics, BTG, Roche/Genentech, and SeaGen. B.K has research funding from AcertaPharma/AstraZeneca Group, Astrazeneca Pharmaceuticals LP, BeiGene Ltd., Roche/Genetech, has been on advisory boards for Abbvie, ADC Therapeutics, Astrazeneca Pharmaceuticals LP, Beigne Ltd., Celgene Corporations, Epizyme Inc., Roche/Genetech, Pharmacyclics, LLC an AbbVie Company, Roche Laboratories Inc, TG Therapeutics Inc and has served on the data \& safety monitoring board/committee for Celgene Corporations, MEI Pharma Inc., Takeda Oncology. C.W.F has research funding from Abbott Laboratories, Roche Diagnostics, Beckman Coulter, The Binding Site, Siemens Healthineers, has consulted for Roche Diagnostics and has had speaking fees from Roche Diagnostics. S.W. has research funding from AbbVie Inc, Ariad Pharmaceuticals, Genentech, Immunomedics, Inc., Millennium Pharmaceuticals Inc, Roche, Astellas Pharma Inc, Daiichi Sankyo, Cullinan Pearl, Verastem Inc, GlaxoSmithKline/GSK, Janssen Research \& Development, LLC, Elevation Oncology, Daiichi Sankyo, Genentech, Loxo Oncology, Takeda Pharmaceuticals Company Limited. S.W. serves on the stat safety monitoring board for Hooiser Cancer Research Network. M.P.W, A.D, C.B., G.S and F.W have no conflicts of interest. Funding Information: The authors would like to thank the Barnes-Jewish Hospital Foundation for support. N. M-S is supported by the Lymphoma Research Foundation. The authors are indebted to the nursing and research staff involved in these studies and to all the participants and their families.",
year = "2022",
doi = "10.1080/10428194.2022.2038377",
language = "English",
volume = "63",
pages = "1723--1727",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
number = "7",
}